Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease

Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease

Abstract Introduction: Hyperparathyroidism (SHPT) secondary to chronic kidney disease (CKD) is characterized by high levels of parathyroid hormone (PTH), hyperplasia of the parathyroid glands and cardiovascular disease. Selective and non-selective and selective vitamin D-receptor activators, calcim...

Full description

Bibliographic Details
Main Authors: Marilia Mastrocolla de Almeida Cardoso, Juliana Machado-Rugolo, Silvana Andrea Molina Lima, Luis Gustavo Modelli de Andrade, Daniel da Silva Pereira Curado, Daniela Ponce
Format: Article
Language:English
Published: Sociedade Brasileira de Nefrologia 2022-08-01
Series:Brazilian Journal of Nephrology
Subjects:
Hyperparathyroidism
Secondary
Renal Insufficiency
Chronic
Paricalcitol
Calcitriol
Cost-Effectiveness Evaluation.
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005041402&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022005041402&tlng=en

Similar Items